Pharmacy

The U.S. Health Resources & Services Administration launched a long-awaited website for safety-net providers participating in the 340B Drug Pricing Program April 1.

Novartis has agreed to acquire a subsidiary of IFM Therapeutics for a potential total of nearly $1.6 billion, including $310 million up front, and up to $1.27 billion in milestone payments, according to Reuters.

After facing pressure from federal regulators, Walgreens Boots Alliance is piloting several tobacco-free stores in the U.S., but doesn't plan to halt sales entirely, according to The Wall Street Journal.

Mylan must face a class-action lawsuit over its lifesaving allergy treatment EpiPen, a judge ruled last week, according to Bloomberg.

Court documents filed by Ohio Attorney General Dave Yost reveal that the state is planning more legal action against pharmacy benefit managers, according to The Columbus Dispatch.

If Purdue Pharma files for bankruptcy to protect itself from thousands of lawsuits claiming the OxyContin maker contributed to the nationwide opioid epidemic, some of its newly created subsidiaries will likely come under scrutiny, according to a STAT news report.

Pharmaceutical companies such as Genentech and AmerisourceBergen Corp. are testing different blockchains to determine whether the technology can track counterfeit drugs, according to Bloomberg Law.

Faced with rising drug costs and shrinking reimbursements, hospitals must look to optimize every area of their organization. Because medications impact virtually every service line of the hospital, the pharmacy is powerful – and often under-utilized – center of innovation.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

In a move to enhance its cancer drug pipeline, AstraZeneca agreed to pay up to $6.9 billion to a Japanese drugmaker for the shared rights to a new cancer drug, according to The Wall Street Journal.